URochester Medicine / Labs / Monaco Lab / Publications

Publications

1. Conley H
2. Oh SY
3. Garrett N
4. Kublin J
5. Monaco CL
6. Watts S
7. Jha S
8. Ferrari G
9. Tomaras GD
10. Geraghty DE
11. Chan C
12. Pollara J
IgG and Fc receptor genetic variation associates with functional antibody responses in a DNA and protein candidate HIV vaccine trial.; Journal of acquired immune deficiency syndromes (1999). 2025 Jul 24.
1. Andrews LIB
2. Halloran ME
3. Neuzil KM
4. van der Laan L
5. Huang Y
6. Andriesen J
7. Patel M
8. Fisher LH
9. Janes H
10. Rouphael N
11. Walsh SR
12. Theodore DA
13. Tieu HV
14. Sobieszczyk M
15. El Sahly HM
16. Baden LR
17. Falsey AR
18. Campbell TB
19. Kelley CF
20. Healy CM
21. Immergluck L
22. Luft B
23. Hirsch I
24. de Bruyn G
25. Truyers C
26. Priddy F
27. Sumner KM
28. Flannery B
29. Follmann D
30. Gilbert PB
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials.; JAMA network open; Vol 8(5), pp. e2512763. 2025 May 01.
1. Orton KL
2. Monaco CL
The Vaginal Virome in Women's Health and Disease.; Microorganisms; Vol 13(2). 2025 Feb 16.
1. Garrett N
2. Dintwe O
3. Monaco CL
4. Jones M
5. Seaton KE
6. Church EC
7. Grunenberg N
8. Hutter J
9. deCamp A
10. Huang Y
11. Lu H
12. Mann P
13. Robinson ST
14. Heptinstall J
15. Jensen RL
16. Pantaleo G
17. Ding S
18. Koutsoukos M
19. Hosseinipour MC
20. Van Der Meeren O
21. Gilbert PB
22. Ferrari G
23. Andersen-Nissen E
24. McElrath MJ
25. Tomaras GD
26. Gray GE
27. Corey L
28. Kublin JG
Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine Trial.; Journal of acquired immune deficiency syndromes (1999); Vol 96(4), pp. 350-360. 2024 Jun 21.
1. Fisher LH
2. Kee JJ
3. Liu A
4. Espinosa CM
5. Randhawa AK
6. Ludwig J
7. Magaret CA
8. Robinson ST
9. Gilbert PB
10. Hyrien O
11. Kublin JG
12. Rouphael N
13. Falsey AR
14. Sobieszczyk ME
15. El Sahly HM
16. Grinsztejn B
17. Gray GE
18. Kotloff KL
19. Gay CL
20. Leav B
21. Hirsch I
22. Struyf F
23. Dunkle LM
24. Neuzil KM
25. Corey L
26. Huang Y
27. Goepfert PA
28. Walsh SR
29. Baden LR
30. Janes H
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.; JAMA network open; Vol 7(5), pp. e2412835. 2024 May 01.
1. Davis EC
2. Monaco C
3. Insel R
4. Järvinen KM
Gut microbiome in the first 1000 days and risk for childhood food allergy.; Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2024 Mar 15.
1. Rick AM
2. Laurens MB
3. Huang Y
4. Yu C
5. Martin TCS
6. Rodriguez CA
7. Rostad CA
8. Maboa RM
9. Baden LR
10. El Sahly HM
11. Grinsztejn B
12. Gray GE
13. Gay CL
14. Gilbert PB
15. Janes HE
16. Kublin JG
17. Huang Y
18. Leav B
19. Hirsch I
20. Struyf F
21. Dunkle LM
22. Neuzil KM
23. Corey L
24. Goepfert PA
25. Walsh SR
26. Follmann D
27. Kotloff KL
Risk of COVID-19 after natural infection or vaccination.; EBioMedicine; Vol 96, pp. 104799. 2023 Sep 20.
1. Theodore DA
2. Branche AR
3. Zhang L
4. Graciaa DS
5. Choudhary M
6. Hatlen TJ
7. Osman R
8. Babu TM
9. Robinson ST
10. Gilbert PB
11. Follmann D
12. Janes H
13. Kublin JG
14. Baden LR
15. Goepfert P
16. Gray GE
17. Grinsztejn B
18. Kotloff KL
19. Gay CL
20. Leav B
21. Miller J
22. Hirsch I
23. Sadoff J
24. Dunkle LM
25. Neuzil KM
26. Corey L
27. Falsey AR
28. El Sahly HM
29. Sobieszczyk ME
30. Huang Y
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.; JAMA network open; Vol 6(7), pp. e2323349. 2023 Jul 03.
1. Goodkin K
2. Evering TH
3. Anderson AM
4. Ragin A
5. Monaco CL
6. Gavegnano C
7. Avery RJ
8. Rourke SB
9. Cysique LA
10. Brew BJ
The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment.; Frontiers in cellular neuroscience; Vol 17, pp. 1130938. 2023 Apr 28.
1. Monaco CL
HIV, AIDS, and the virome: Gut reactions.; Cell host & microbe; Vol 30(4). 2022 Apr 13.
1. Madere FS
2. Sohn M
3. Winbush AK
4. Barr B
5. Grier A
6. Palumbo C
7. Java J
8. Meiring T
9. Williamson AL
10. Bekker LG
11. Adler DH
12. Monaco CL
Transkingdom Analysis of the Female Reproductive Tract Reveals Bacteriophages form Communities.; Viruses; Vol 14(2). 2022 Feb 19.
1. Madere FS
2. Monaco CL
The female reproductive tract virome: understanding the dynamic role of viruses in gynecological health and disease.; Current opinion in virology; Vol 52. 2022 Feb.
1. Falsey AR
2. Sobieszczyk ME
3. Hirsch I
4. Sproule S
5. Robb ML
6. Corey L
7. Neuzil KM
8. Hahn W
9. Hunt J
10. Mulligan MJ
11. McEvoy C
12. DeJesus E
13. Hassman M
14. Little SJ
15. Pahud BA
16. Durbin A
17. Pickrell P
18. Daar ES
19. Bush L
20. Solis J
21. Carr QO
22. Oyedele T
23. Buchbinder S
24. Cowden J
25. Vargas SL
26. Benavides AG
27. Call R
28. Keefer MC
29. Kirkpatrick BD
30. Pullman J
31. Tong T
32. Isaacs MB
33. Benkeser D
34. Janes HE
35. Nason MC
36. Green JA
37. Kelly EJ
38. Maaske J
39. Mueller N
40. Shoemaker K
41. Takas T
42. Marshall RP
43. Pangalos MN
44. Villafana T
45. Gonzalez-Lopez A
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.; The New England journal of medicine. 2021 Sep 29.
1. Corey L
2. Gilbert PB
3. Juraska M
4. Montefiori DC
5. Morris L
6. Karuna ST
7. Edupuganti S
8. Mgodi NM
9. deCamp AC
10. Rudnicki E
11. Huang Y
12. Gonzales P
13. Cabello R
14. Orrell C
15. Lama JR
16. Laher F
17. Lazarus EM
18. Sanchez J
19. Frank I
20. Hinojosa J
21. Sobieszczyk ME
22. Marshall KE
23. Mukwekwerere PG
24. Makhema J
25. Baden LR
26. Mullins JI
27. Williamson C
28. Hural J
29. McElrath MJ
30. Bentley C
31. Takuva S
32. Gomez Lorenzo MM
33. Burns DN
34. Espy N
35. Randhawa AK
36. Kochar N
37. Piwowar-Manning E
38. Donnell DJ
39. Sista N
40. Andrew P
41. Kublin JG
42. Gray G
43. Ledgerwood JE
44. Mascola JR
45. Cohen MS
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.; The New England journal of medicine; Vol 384(11). 2021 Mar 18.
1. Monaco CL
2. Kwon DS
Next-generation Sequencing of the DNA Virome from Fecal Samples.; Bio-protocol; Vol 7(5). 2017 Mar 05.
1. Monaco CL
2. Gootenberg DB
3. Zhao G
4. Handley SA
5. Ghebremichael MS
6. Lim ES
7. Lankowski A
8. Baldridge MT
9. Wilen CB
10. Flagg M
11. Norman JM
12. Keller BC
13. Luévano JM
14. Wang D
15. Boum Y
16. Martin JN
17. Hunt PW
18. Bangsberg DR
19. Siedner MJ
20. Kwon DS
21. Virgin HW
Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.; Cell host & microbe; Vol 19(3). 2016 Mar 09.
1. Handley SA
2. Desai C
3. Zhao G
4. Droit L
5. Monaco CL
6. Schroeder AC
7. Nkolola JP
8. Norman ME
9. Miller AD
10. Wang D
11. Barouch DH
12. Virgin HW
SIV Infection-Mediated Changes in Gastrointestinal Bacterial Microbiome and Virome Are Associated with Immunodeficiency and Prevented by Vaccination.; Cell host & microbe; Vol 19(3). 2016 Mar 09.
1. Wilen CB
2. Monaco CL
3. Hoppe-Bauer J
4. Jackups R
5. Bucelli RC
6. Burnham CA
Criteria for reducing unnecessary testing for herpes simplex virus, varicella-zoster virus, cytomegalovirus, and enterovirus in cerebrospinal fluid samples from adults.; Journal of clinical microbiology; Vol 53(3). 2015 Mar.
1. Norman JM
2. Handley SA
3. Baldridge MT
4. Droit L
5. Liu CY
6. Keller BC
7. Kambal A
8. Monaco CL
9. Zhao G
10. Fleshner P
11. Stappenbeck TS
12. McGovern DP
13. Keshavarzian A
14. Mutlu EA
15. Sauk J
16. Gevers D
17. Xavier RJ
18. Wang D
19. Parkes M
20. Virgin HW
Disease-specific alterations in the enteric virome in inflammatory bowel disease.; Cell; Vol 160(3). 2015 Jan 29.
1. Keller BC
2. Johnson CL
3. Erickson AK
4. Gale M
Innate immune evasion by hepatitis C virus and West Nile virus.; Cytokine & growth factor reviews; Vol 18(5-6). 2007 Oct.
1. Johnson CL
2. Owen DM
3. Gale M
Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.; The Journal of biological chemistry; Vol 282(14). 2007 Apr 06.
1. Saito T
2. Hirai R
3. Loo YM
4. Owen D
5. Johnson CL
6. Sinha SC
7. Akira S
8. Fujita T
9. Gale M
Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2.; Proceedings of the National Academy of Sciences of the United States of America; Vol 104(2). 2007 Jan 09.
1. Chien Y
2. Kim S
3. Bumeister R
4. Loo YM
5. Kwon SW
6. Johnson CL
7. Balakireva MG
8. Romeo Y
9. Kopelovich L
10. Gale M
11. Yeaman C
12. Camonis JH
13. Zhao Y
14. White MA
RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival.; Cell; Vol 127(1). 2006 Oct 06.
1. Loo YM
2. Owen DM
3. Li K
4. Erickson AK
5. Johnson CL
6. Fish PM
7. Carney DS
8. Wang T
9. Ishida H
10. Yoneyama M
11. Fujita T
12. Saito T
13. Lee WM
14. Hagedorn CH
15. Lau DT
16. Weinman SA
17. Lemon SM
18. Gale M
Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection.; Proceedings of the National Academy of Sciences of the United States of America; Vol 103(15). 2006 Apr 11.
1. Johnson CL
2. Gale M
CARD games between virus and host get a new player.; Trends in immunology; Vol 27(1). 2006 Jan.
1. Foy E
2. Li K
3. Sumpter R
4. Loo YM
5. Johnson CL
6. Wang C
7. Fish PM
8. Yoneyama M
9. Fujita T
10. Lemon SM
11. Gale M
Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.; Proceedings of the National Academy of Sciences of the United States of America; Vol 102(8). 2005 Feb 22.
1. Brzostowski JA
2. Johnson C
3. Kimmel AR
Galpha-mediated inhibition of developmental signal response.; Current biology : CB; Vol 12(14). 2002 Jul 23.
1. Henderson CW
2. Johnson CL
3. Lodhi SA
4. Bilimoria SL
Replication of Chilo iridescent virus in the cotton boll weevil, Anthonomus grandis, and development of an infectivity assay.; Archives of virology; Vol 146(4). 2001.